Biomarkers in Patients With Anemia-Induced Thrombocytopenic Bleeding

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 11, 2025

Primary Completion Date

November 1, 2026

Study Completion Date

November 1, 2026

Conditions
Acute LeukemiaAcute Myeloid Leukemia (AML)Acute Lymphocytic Leukaemia
Interventions
PROCEDURE

RBC transfusion strategy

RBC transfusion strategy to maintain a hemoglobin level of at least 110 g/L.

Trial Locations (1)

L8V 1C3

RECRUITING

Juravinski Hospital, Hamilton

All Listed Sponsors
lead

Donald Arnold

OTHER